Smartphone Flicker Fusion Test for Patients With Optic Disorders.
Launched by RANDY KARDON · Mar 16, 2018
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new smartphone app called eyeFusion, which helps measure something called "flicker fusion." This is a quick and easy way to assess how well your eyes are functioning, especially for patients with a specific vision problem known as scotoma, where part of the visual field is missing. The goal is to see if this app can be a useful tool for doctors to gather important information about eye health during routine care.
To participate in this study, you should be between 18 and 80 years old. If you have scotoma, you may qualify as a patient. Healthy individuals without any eye disorders can also join as control participants. During the trial, you'll simply use the app to perform the test, which should be straightforward and not take much time. This research might help improve how doctors diagnose and manage optic disorders in the future. If you’re interested, you can reach out to learn more about joining the study!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Control
- • Age matched 18-80 years of age.
- • Healthy normal controls with no known eye disorders.
- Exclusion Criteria:
- • Scotoma or any other ocular disorder
- • Inclusion Criteria - Patients
- • Age 18-80
- • Clinically associated scotoma
- • Exclusion Criteria - Patients
- • -Any other ocular disorder
About Randy Kardon
Randy Kardon is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a strong background in clinical medicine and a focus on innovative therapeutic solutions, he leads initiatives that explore cutting-edge treatments across various health conditions. Under his guidance, clinical trials are conducted with rigorous adherence to ethical standards and regulatory compliance, ensuring the highest quality of data collection and analysis. Randy Kardon’s dedication to collaboration and transparency fosters partnerships with academic institutions, healthcare providers, and industry stakeholders, driving forward the development of safe and effective medical interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Iowa City, Iowa, United States
Patients applied
Trial Officials
Randy Kardon, MD, PhD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials